Logo image of 1SHL.MI

SIEMENS HEALTHINEERS AG (1SHL.MI) Stock Fundamental Analysis

BIT:1SHL - DE000SHL1006 - Common Stock

47.3 EUR
+0.92 (+1.98%)
Last: 8/27/2025, 7:00:00 PM
Fundamental Rating

5

Taking everything into account, 1SHL scores 5 out of 10 in our fundamental rating. 1SHL was compared to 58 industry peers in the Health Care Equipment & Supplies industry. 1SHL has a medium profitability rating, but doesn't score so well on its financial health evaluation. 1SHL is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

1SHL had positive earnings in the past year.
In the past year 1SHL had a positive cash flow from operations.
Each year in the past 5 years 1SHL has been profitable.
Each year in the past 5 years 1SHL had a positive operating cash flow.
1SHL.MI Yearly Net Income VS EBIT VS OCF VS FCF1SHL.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

1.2 Ratios

1SHL has a better Return On Assets (4.87%) than 66.67% of its industry peers.
With a decent Return On Equity value of 12.29%, 1SHL is doing good in the industry, outperforming 75.44% of the companies in the same industry.
1SHL has a better Return On Invested Capital (7.89%) than 71.93% of its industry peers.
The Average Return On Invested Capital over the past 3 years for 1SHL is below the industry average of 8.86%.
The 3 year average ROIC (5.87%) for 1SHL is below the current ROIC(7.89%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.87%
ROE 12.29%
ROIC 7.89%
ROA(3y)3.87%
ROA(5y)4.27%
ROE(3y)9.76%
ROE(5y)10.27%
ROIC(3y)5.87%
ROIC(5y)6.49%
1SHL.MI Yearly ROA, ROE, ROIC1SHL.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

1SHL has a better Profit Margin (9.29%) than 68.42% of its industry peers.
1SHL's Profit Margin has declined in the last couple of years.
1SHL has a better Operating Margin (13.76%) than 66.67% of its industry peers.
1SHL's Operating Margin has declined in the last couple of years.
1SHL has a worse Gross Margin (38.76%) than 75.44% of its industry peers.
1SHL's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 13.76%
PM (TTM) 9.29%
GM 38.76%
OM growth 3Y-4.02%
OM growth 5Y-4.5%
PM growth 3Y-3.26%
PM growth 5Y-4.26%
GM growth 3Y-0.66%
GM growth 5Y-1.05%
1SHL.MI Yearly Profit, Operating, Gross Margins1SHL.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 1SHL is creating some value.
Compared to 1 year ago, 1SHL has more shares outstanding
1SHL has more shares outstanding than it did 5 years ago.
The debt/assets ratio for 1SHL has been reduced compared to a year ago.
1SHL.MI Yearly Shares Outstanding1SHL.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
1SHL.MI Yearly Total Debt VS Total Assets1SHL.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.2 Solvency

1SHL has an Altman-Z score of 2.08. This is not the best score and indicates that 1SHL is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.08, 1SHL perfoms like the industry average, outperforming 47.37% of the companies in the same industry.
The Debt to FCF ratio of 1SHL is 5.10, which is a neutral value as it means it would take 1SHL, 5.10 years of fcf income to pay off all of its debts.
1SHL has a Debt to FCF ratio of 5.10. This is comparable to the rest of the industry: 1SHL outperforms 57.89% of its industry peers.
1SHL has a Debt/Equity ratio of 0.66. This is a neutral value indicating 1SHL is somewhat dependend on debt financing.
The Debt to Equity ratio of 1SHL (0.66) is worse than 70.18% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 5.1
Altman-Z 2.08
ROIC/WACC1.32
WACC5.98%
1SHL.MI Yearly LT Debt VS Equity VS FCF1SHL.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

1SHL has a Current Ratio of 1.12. This is a normal value and indicates that 1SHL is financially healthy and should not expect problems in meeting its short term obligations.
1SHL has a Current ratio of 1.12. This is in the lower half of the industry: 1SHL underperforms 73.68% of its industry peers.
A Quick Ratio of 0.77 indicates that 1SHL may have some problems paying its short term obligations.
The Quick ratio of 1SHL (0.77) is worse than 71.93% of its industry peers.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 0.77
1SHL.MI Yearly Current Assets VS Current Liabilites1SHL.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 11.21% over the past year.
The Earnings Per Share has been growing slightly by 7.27% on average over the past years.
1SHL shows a small growth in Revenue. In the last year, the Revenue has grown by 5.85%.
The Revenue has been growing by 9.02% on average over the past years. This is quite good.
EPS 1Y (TTM)11.21%
EPS 3Y3.35%
EPS 5Y7.27%
EPS Q2Q%23.08%
Revenue 1Y (TTM)5.85%
Revenue growth 3Y7.51%
Revenue growth 5Y9.02%
Sales Q2Q%4.41%

3.2 Future

1SHL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.80% yearly.
Based on estimates for the next years, 1SHL will show a small growth in Revenue. The Revenue will grow by 5.17% on average per year.
EPS Next Y9.58%
EPS Next 2Y8.35%
EPS Next 3Y9.57%
EPS Next 5Y9.8%
Revenue Next Year4.94%
Revenue Next 2Y4.73%
Revenue Next 3Y5.15%
Revenue Next 5Y5.17%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
1SHL.MI Yearly Revenue VS Estimates1SHL.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10B 20B 30B
1SHL.MI Yearly EPS VS Estimates1SHL.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 19.87, the valuation of 1SHL can be described as rather expensive.
1SHL's Price/Earnings ratio is rather cheap when compared to the industry. 1SHL is cheaper than 80.70% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.02, 1SHL is valued a bit cheaper.
1SHL is valuated rather expensively with a Price/Forward Earnings ratio of 18.07.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 1SHL indicates a somewhat cheap valuation: 1SHL is cheaper than 70.18% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.66, 1SHL is valued a bit cheaper.
Industry RankSector Rank
PE 19.87
Fwd PE 18.07
1SHL.MI Price Earnings VS Forward Price Earnings1SHL.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1SHL indicates a somewhat cheap valuation: 1SHL is cheaper than 66.67% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, 1SHL is valued cheaper than 85.96% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.35
EV/EBITDA 14.59
1SHL.MI Per share data1SHL.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
1SHL has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.08
PEG (5Y)2.73
EPS Next 2Y8.35%
EPS Next 3Y9.57%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.02%, 1SHL has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.16, 1SHL pays a better dividend. On top of this 1SHL pays more dividend than 80.70% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.45, 1SHL has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.02%

5.2 History

The dividend of 1SHL is nicely growing with an annual growth rate of 6.35%!
Dividend Growth(5Y)6.35%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

49.08% of the earnings are spent on dividend by 1SHL. This is a bit on the high side, but may be sustainable.
The dividend of 1SHL is growing, but earnings are growing more, so the dividend growth is sustainable.
DP49.08%
EPS Next 2Y8.35%
EPS Next 3Y9.57%
1SHL.MI Yearly Income VS Free CF VS Dividend1SHL.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B
1SHL.MI Dividend Payout.1SHL.MI Dividend Payout, showing the Payout Ratio.1SHL.MI Dividend Payout.PayoutRetained Earnings

SIEMENS HEALTHINEERS AG

BIT:1SHL (8/27/2025, 7:00:00 PM)

47.3

+0.92 (+1.98%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)07-30 2025-07-30/dmh
Earnings (Next)11-05 2025-11-05/amc
Inst Owners10.84%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap53.35B
Analysts83.7
Price Target61.74 (30.53%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.02%
Yearly Dividend0.95
Dividend Growth(5Y)6.35%
DP49.08%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.66%
Min EPS beat(2)-2.04%
Max EPS beat(2)13.36%
EPS beat(4)3
Avg EPS beat(4)5.82%
Min EPS beat(4)-2.04%
Max EPS beat(4)13.36%
EPS beat(8)5
Avg EPS beat(8)3.25%
EPS beat(12)8
Avg EPS beat(12)3.67%
EPS beat(16)10
Avg EPS beat(16)2.87%
Revenue beat(2)1
Avg Revenue beat(2)-0.25%
Min Revenue beat(2)-0.77%
Max Revenue beat(2)0.27%
Revenue beat(4)2
Avg Revenue beat(4)-0.01%
Min Revenue beat(4)-0.81%
Max Revenue beat(4)1.29%
Revenue beat(8)3
Avg Revenue beat(8)-0.4%
Revenue beat(12)4
Avg Revenue beat(12)-0.45%
Revenue beat(16)8
Avg Revenue beat(16)0.12%
PT rev (1m)-0.85%
PT rev (3m)-0.85%
EPS NQ rev (1m)-2.8%
EPS NQ rev (3m)-16.03%
EPS NY rev (1m)-2.35%
EPS NY rev (3m)-2.35%
Revenue NQ rev (1m)0.05%
Revenue NQ rev (3m)-4.82%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)-0.71%
Valuation
Industry RankSector Rank
PE 19.87
Fwd PE 18.07
P/S 2.28
P/FCF 17.35
P/OCF 13.87
P/B 3.02
P/tB N/A
EV/EBITDA 14.59
EPS(TTM)2.38
EY5.03%
EPS(NY)2.62
Fwd EY5.53%
FCF(TTM)2.73
FCFY5.77%
OCF(TTM)3.41
OCFY7.21%
SpS20.73
BVpS15.67
TBVpS-5.42
PEG (NY)2.08
PEG (5Y)2.73
Profitability
Industry RankSector Rank
ROA 4.87%
ROE 12.29%
ROCE 10.07%
ROIC 7.89%
ROICexc 8.64%
ROICexgc 46.76%
OM 13.76%
PM (TTM) 9.29%
GM 38.76%
FCFM 13.16%
ROA(3y)3.87%
ROA(5y)4.27%
ROE(3y)9.76%
ROE(5y)10.27%
ROIC(3y)5.87%
ROIC(5y)6.49%
ROICexc(3y)6.25%
ROICexc(5y)6.86%
ROICexgc(3y)30.57%
ROICexgc(5y)31.67%
ROCE(3y)7.49%
ROCE(5y)8.29%
ROICexcg growth 3Y-8.79%
ROICexcg growth 5Y-3.88%
ROICexc growth 3Y1.69%
ROICexc growth 5Y-10.54%
OM growth 3Y-4.02%
OM growth 5Y-4.5%
PM growth 3Y-3.26%
PM growth 5Y-4.26%
GM growth 3Y-0.66%
GM growth 5Y-1.05%
F-Score8
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 5.1
Debt/EBITDA 2.58
Cap/Depr 59.37%
Cap/Sales 3.29%
Interest Coverage 7.09
Cash Conversion 85.2%
Profit Quality 141.62%
Current Ratio 1.12
Quick Ratio 0.77
Altman-Z 2.08
F-Score8
WACC5.98%
ROIC/WACC1.32
Cap/Depr(3y)58.06%
Cap/Depr(5y)61.48%
Cap/Sales(3y)3.63%
Cap/Sales(5y)3.7%
Profit Quality(3y)91.88%
Profit Quality(5y)100.74%
High Growth Momentum
Growth
EPS 1Y (TTM)11.21%
EPS 3Y3.35%
EPS 5Y7.27%
EPS Q2Q%23.08%
EPS Next Y9.58%
EPS Next 2Y8.35%
EPS Next 3Y9.57%
EPS Next 5Y9.8%
Revenue 1Y (TTM)5.85%
Revenue growth 3Y7.51%
Revenue growth 5Y9.02%
Sales Q2Q%4.41%
Revenue Next Year4.94%
Revenue Next 2Y4.73%
Revenue Next 3Y5.15%
Revenue Next 5Y5.17%
EBIT growth 1Y18.19%
EBIT growth 3Y3.18%
EBIT growth 5Y4.12%
EBIT Next Year49.6%
EBIT Next 3Y21.79%
EBIT Next 5Y15.45%
FCF growth 1Y161.12%
FCF growth 3Y-1.94%
FCF growth 5Y15.48%
OCF growth 1Y86.79%
OCF growth 3Y-1.23%
OCF growth 5Y11.83%